CUE
Cue Biopharma, Inc.
Latest Form 4:Purchase$100KbySarraf Pasha (Director) · filed Jan 2, 2026
Cue Biopharma, Inc. (CUE) has 11 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 3, 2026.
- Industry:Biotechnology
- CEO:Lucinda Warren
- Employees:41
- HQ:Boston, MA, US
- IPO:2018-01-02
Insider Buying
$100K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$123.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Sarraf PashaFirst filing | Director | Purchase | 10,796 | $100K | Jan 2 | SEC ↗ |
Related companies
Cue Biopharma, Inc. is in the Healthcare sector.